Refine by
Neuromuscular Junction Equipment & Supplies
12 equipment items found
Manufactured by:SEQENS Group based inÉcully, FRANCE
Sugammadex is an octasaccharide derivative used for reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery. The encapsulation by sugammadex blocks the ability of the neuromuscular blocking agents to bind to nicotinic receptors in the neuromuscular junction and thereby ...
Manufactured by:Allengers Global Healthcare Private Limited based inChandigarh, INDIA
The latest digital technology offers the physician greater flexibility in recording and interpreting EMG, finding diseases that can damage muscle tissue, nerves, or the junctions between nerve and muscle (neuromuscular junction). Electromyography (EMG) is a technique for evaluating and recording the electrical activity produced by skeletal ...
Manufactured by:Allengers Global Healthcare Private Limited based inChandigarh, INDIA
Allengers Scorpio Series of EMG, EP test system are designed using state-of-the-art technology for Innovation of using computer technology to record the EMG, EP and NCS has brought diagnostic neurology to the edge of the 21st century finding diseases that damage muscle tissue, nerves, or the junctions between nerve and muscle (neuromuscular ...
Manufactured by:Cabaletta Bio, Inc. based inPhiladelphia, PENNSYLVANIA (USA)
Precision Approach to Address the Underlying Cause of Disease: Our second candidate, MuSK-CAART, is designed to treat myasthenia gravis (MG), an autoimmune disease affecting the neuromuscular junction that can lead to motor impairment, muscle weakness, and respiratory ...
Manufactured by:eNUVIO inc. based inMontreal, QUEBEC (CANADA)
Get more out of your neuronal cultures and co-cultures with the latest in microfluidic devices from eNUVIO. OMEGA4 devices can be used for in vitro co-culture studies of neurodegeneration, neuromuscular junction (NMJ), nigrostriatal pathway, pain, myelination, or chemotactic factors. In single culture applications, the OMEGA4 can serve as a compartmentalization ...
Manufactured by:eNUVIO inc. based inMontreal, QUEBEC (CANADA)
Get even more out of your neuronal cultures and co-cultures with the latest in microfluidic devices from eNUVIO. OMEGAACE devices can be used for in vitro triple co-culture studies of neurodegeneration, neuromuscular junction (NMJ), nigrostriatal pathway, pain, myelination, or chemotactic factors. In single culture applications, the OMEGAACE can also serve as a ...
Manufactured by:eNUVIO inc. based inMontreal, QUEBEC (CANADA)
Each experimental unit consists of one standard sized chamber and one small chamber. OMEGA4-2mini devices can be used for in vitro co-culture studies of neurodegeneration, neuromuscular junction (NMJ), nigrostriatal pathway, pain, myelination, or chemotactic factors. In single culture applications, the OMEGA4-2mini can serve as a compartmentalization tool to ...
Manufactured by:eNUVIO inc. based inMontreal, QUEBEC (CANADA)
Each experimental unit consists of one standard sized chamber and one small chamber. OMEGA4-2mini-2mm devices can be used for in vitro co-culture studies of neurodegeneration, neuromuscular junction (NMJ), nigrostriatal pathway, pain, myelination, or chemotactic factors. In single culture applications, the OMEGA4-2mini-2mm can serve as a compartmentalization ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
α-CGRP (mouse, rat), a neuropeptide (calcitonin gene-related peptide (CGRP)) mainly expressed in neuromuscular junction, is a potent vasodilator. α-CGRP (mouse, rat) can lead to a fall in blood pressure and an increase in heart rate by peripheral administration, also relax colonie smooth muscle. α-CGRP (mouse, rat) has the potential in cardiovascular, ...
by:CuraVac Europe S.A. based inRixensart, BELGIUM
CuraVac is a clinical-stage biotechnology company developing the medical and commercial potential of a revolutionary technique for the production of specific Therapeutic Vaccines (or Active Targeted Immunotherapies) for autoimmune ...
by:Pure Biologics SA based inWroclaw, POLAND
Myasthenia gravis (MG) is an autoimmune condition classified as a rare disease. Accordingly, myasthenic patients lack effective treatment options, as this rare disease is not a primary interest of the pharmaceutical industry. However, considerable social and institutional support exists for the development of new therapies to treat rare diseases. The PB005 (AptaMG) project aims to develop a novel ...
by:CuraVac Europe S.A. based inRixensart, BELGIUM
The MYASTERIX project (2013 – 2018) advanced a Therapeutic Vaccine candidate (designated orphan drug) indicated for myasthenia gravis (MG) to clinical proof of concept ...